Key Takeaway: Vor Bio, a clinical-stage cell and genome engineering company, will participate in the Stifel 2024 Healthcare Conference. The event includes a fireside chat scheduled for November 18, 2024, in New York City. Vor Bio's work focuses on engineering hematopoietic stem cells to improve post-transplant therapies for patients with blood cancers. Investors can access a live webcast of the discussion via Vor Bio's website.
Price reaction · baseline $20.2 (2024-11-11 close) · hit after-hours · clean, no other VOR news in the window
day 0 close · peak
-2%
Market Sentiment Analysis
POSITIVE FACTORS
Vor Bio is actively participating in important healthcare conferences which indicates engagement with investors.
The fireside chat showcases their innovative approach in cell and genome engineering.
The company's focus on changing the standard of care for blood cancer patients is a strong positive aspect.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+442%
120-day peak, hindsight
Typical move
18.8%
average across 6 past catalysts
Cash runway
~55 mo
Minimal dilution risk
Lead asset
Telitacicept
Phase 3 · Primary Sjogren's Disease
Full Press Release Details
CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host 1x1 investor meetings at the Stifel 2024 Healthcare Conference.
Stifel 2024 Healthcare Conference
Fireside Chat: Monday, November 18, 2024 at 2:25 pm ET
Location: New York, NY
A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Frequently Asked Questions
What is Vor Bio's focus in biopharma?
Vor Bio specializes in cell and genome engineering for blood cancer treatments.
When is the fireside chat at the Stifel Conference?
The fireside chat is on November 18, 2024, at 2:25 pm ET.
Where will the Stifel 2024 Healthcare Conference be held?
The conference will take place in New York, NY.
How can I access the fireside chat replay?
The webcast and replay will be available on Vor Bio's investor section.
What type of cancers does Vor Bio target?
Vor Bio targets blood cancers, including acute myeloid leukemia.